The Clanwilliam Group has welcomed Obsidian Healthcare, its 17th business to join the fast-growing group.
The Obsidian Healthcare Group educates tens of thousands of healthcare professionals across the globe each year on new innovations, drugs and clinical best practice.
The company works with clinical experts to design and deliver innovative educational programmes for pharma, biotech and healthcare organisations worldwide, as well as grant providers and medical societies. These programmes have helped countless healthcare professionals to address clinical priorities, share best practice internationally and, ultimately, improve patient care and clinical outcomes.
Clanwilliam Group also confirmed in November that it had completed a €200m debt placement with asset management firm Alcentra, in order to refinance existing facilities and to finance near term acquisitions, with a further €100m of follow-on capital earmarked for future growth.
Dr Wendy Mathias, founder and CEO of Obsidian Healthcare Group, said: “Becoming part of Clanwilliam Group marks a major step in expanding our ability to accomplish the educational goals of our clients and grant providers across the world. Obsidian has always been driven by our vision of doing things differently, and it was critical to me to find an investment partner who not only values our distinctive ethos, attitudes and commitment to quality, but also shares our passion for improving healthcare outcomes.”
“We will remain focussed on delivering medical education based on scientific rigour, and at the same time enhancing our services by drawing on the digital technologies, expertise and resources of the wider Clanwilliam family. I will remain CEO of Obsidian and look forward to contributing to the connected health vision of Clanwilliam Group, helping to link technologies and innovations in the group with clinical and educational needs, as well as being the fulcrum of a new division for the company.”
Howard Beggs, CEO of Clanwilliam Group, said: “The long-standing success that Obsidian Healthcare Group has had across the world in helping to distil crucial information to healthcare professionals through high-impact education programmes, will be an invaluable asset to Clanwilliam Group. Not only do we expect to see new opportunities in new markets as a result of our investment in Obsidian, but the addition offers the potential to build our reputation as a trusted intermediary between innovation, clinical need and patient outcomes, as we continue to expand our M&A ambitions.”
